Invention Grant
- Patent Title: Prevention and treatment of synucleinopathic and amyloidogenic disease
-
Application No.: US12037081Application Date: 2008-02-25
-
Publication No.: US08092801B2Publication Date: 2012-01-10
- Inventor: Dale B. Schenk , Eliezar Masliah , Manuel J. Buttini , Tamie J. Chilcote , Edward Rockenstein , Kate Dora Games
- Applicant: Dale B. Schenk , Eliezar Masliah , Manuel J. Buttini , Tamie J. Chilcote , Edward Rockenstein , Kate Dora Games
- Applicant Address: IE Dublin
- Assignee: Neotope Biosciences Limited
- Current Assignee: Neotope Biosciences Limited
- Current Assignee Address: IE Dublin
- Agency: Alston and Bird LLP
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The invention provides improved agents and methods for treatment of diseases associated with synucleinopathic diseases, including Lewy bodies of alpha-synuclein in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the Lewy body. The methods are particularly useful for prophylactic and therapeutic treatment of Parkinson's disease.
Public/Granted literature
- US20100278814A1 Prevention and treatment of synucleinopathic and amyloidogenic disease Public/Granted day:2010-11-04
Information query
